NASDAQ:ORIAU

Orion Biotech Opportunities (ORIAU) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$9.00
$9.00
50-Day Range
$9.80
$10.02
52-Week Range
$9.61
$10.85
Volume
N/A
Average Volume
1,550 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

About Orion Biotech Opportunities

Orion Biotech Opportunities Corp., a blank check company, intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or related business combination with one or more businesses or entities. The company was founded in 2021 and is based in New York, New York.

ORIAU Stock News Headlines

Orion Office REIT: The Downturn Continues
Mysterious Gold Leverage Just Announced
World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.
Albany News
Orion: 3 Reasons There Could Be Material Downside In 2024
Mysterious Gold Leverage Just Announced
World's biggest multibillionaire investor group is buying THIS by the tons Most folks have completely missed the fact that there's one group of investors so powerful they're literally buying ONE THING by the tons… Stacking it in their locked vaults on pallets in record numbers.
Orion Biotech Opportunities Corp (ORIA)
Orion Biotech Opportunities Corp. (ORIAW)
Orion Biotech Opportunities Corp.
See More Headlines
Receive ORIAU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Orion Biotech Opportunities and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
Finance
Industry
Shell Companies
Sub-Industry
N/A
Current Symbol
NASDAQ:ORIAU
Web
N/A
Phone
N/A
Fax
N/A
Employees
2,021
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
13 Stocks Institutional Investors Won't Stop Buying Cover

Which stocks are major institutional investors including hedge funds and endowments buying in today's market? Click the link below and we'll send you MarketBeat's list of thirteen stocks that institutional investors are buying up as quickly as they can.

Get This Free Report

Key Executives

  • Mr. Zuie-Chin Huang M.B.A. (Age 55)
    CEO & Director
  • Mr. Mark Kayal (Age 36)
    CFO & Sec.
  • Mr. Robert Kenneth Simonds (Age 47)
    Gen. Counsel, Assistant Sec., VP & Director

ORIAU Stock Analysis - Frequently Asked Questions

When did Orion Biotech Opportunities IPO?

Orion Biotech Opportunities (ORIAU) raised $200 million in an IPO on Thursday, May 13th 2021. The company issued 20,000,000 shares at $10.00 per share. Cantor served as the underwriter for the IPO.

This page (NASDAQ:ORIAU) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners